Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Aug 16, 2023; 11(23): 5430-5439
Published online Aug 16, 2023. doi: 10.12998/wjcc.v11.i23.5430
Table 2 Analysis of surgery-related risk factors in the two groups, n (%)

Hemorrhage group, n = 6
Control group, n = 30
P value
Surgery time (min)177.50 ± 50.97149.67 ± 69.060.357
Blood loss during surgery (mL)433.33 ± 350.24327.67 ± 301.940.451
Max systolic BP (mmHg)150.00 ± 22.14139.47 ± 27.340.381
Fluctuating systolic BP (mmHg)47.50 ± 16.6639.00 ± 17.490.282
Dura damage3 (50.0)1 (3.3)0.010a
Fusion instrument4 (66.7)10 (33.3)0.181
Pedicle screw fixation4 (66.7)23 (76.7)0.627
Plasma transfusion (mL)633.33 ± 898.1520.00 ± 109.550.155
RBC transfusion (U)2.00 ± 2.530.20 ± 0.810.143
Subfascial drainage (mL)1804.83 ± 1284.60695.33 ± 507.850.088